A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purposes of this study are to characterize the pharmacokinetics of paliperidone after single- and multiple-dose administration of paliperidone ER in children and adolescent patients (\>= 10 to \<= 17 years of age) with schizophrenia, schizoaffective disorder, or schizophreniform disorder and to evaluate the safety and tolerability of paliperidone ER in this patient population.
Epistemonikos ID: 5ebf90c688f19f4d9e58a3f98d896b11ef65228d
First added on: May 05, 2024